Skip to Content

New Drug Approvals Archive - January 2005

See also: New Indications and Dosage Forms for January 2005

January 2005

Abraxane (paclitaxel protein-bound) for Injectable Suspension

Date of Approval: January 7, 2005
Company: American Pharmaceutical Partners, Inc. / American Bioscience, Inc.
Treatment for: Breast Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer

Abraxane (paclitaxel protein-bound) is an albumin-bound form of the antineoplastic agent paclitaxel indicated for the treatment of breast cancer, non-small cell lung cancer, and pancreatic cancer.

ThyroShield (potassium iodide) Oral Solution

Date of Approval: January 12, 2005
Company: Fleming & Company
Treatment for: Radiation Emergency

ThyroShield (potassium iodide) is used to protect the thyroid gland from the effects of radiation from inhaled or swallowed radioactive iodine.

Menactra (meningococcal conjugate vaccine)

Date of Approval: January 14, 2005
Company: Sanofi Pasteur
Treatment for: Meningococcal Meningitis Prophylaxis

Menactra (meningococcal conjugate vaccine) is a quadrivalent conjugate vaccine indicated for the prevention of meningococcal disease.

Niravam (alprazolam) Orally Disintegrating Tablets

Date of Approval: January 19, 2005
Treatment for: Anxiety, Panic Disorder

Marketing Status: Discontinued

Niravam (alprazolam) is an orally disintegrating benzodiazepine indicated for the short-term relief of anxiety and panic attacks.

New Drug Approvals Archive

More News Resources

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.